Skip to Content

Set Your Location to See Relevant Information

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.

MyBillingsClinic

SHARE

Clinical Trials Details

VITAL

A Randomized, Double-Blind, Placebo-Controlled Phase II/III Trial of Vigil Augumented Autologous Tumor Cell Immunotherapy in Subjects with Stage III/IV Ovarian Cancer in Clinical Complete Response following Surgery and Primary Chemotherapy (VITAL)

Objective

Part I Patient consents for tissue collection at time of surgery.

No neo-adjuvant therapy is allowed prior to tissue collection.

Presumptive Stage III/IV high grade serous/endometrioid ovarian, fallopian tube or primary peritioneal cancer

Part II Completion of primary surgical debulking and at least 5 by no more than 6 cycles platinum/taxane adjuvant chemotherapy.

Clinically defined Complete Response following completion of therapy.

Must initiate adjuvant chemotherapy no more than 8 weeks following surgery.

 

 

IRB Protocol Number
CL-PTL-119
Contact
Judy Miller, RN CCRP at 406-435-7482
or jmiller4@billingsclinic.org

Location

  • Billings Clinic Hospital Fountain Courtyard - South of the Hospital Cafeteria
    2750 9th Ave North
    Billings, MT 59101